ACD Solution Modified (AnazaoHealth Corporation)


Welcome to the PulseAid listing for the ACD Solution Modified drug offered from AnazaoHealth Corporation. This Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: AnazaoHealth Corporation
NON-PROPRIETARY NAME: ACD Solution Modified
SUBSTANCE NAME: ANHYDROUS CITRIC ACID
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA]
ROUTE: INTRAVENOUS
DOSAGE FORM: SOLUTION
MARKETING CATEGORY NAME: UNAPPROVED DRUG OTHER
START MARKETING DATE: 2012-05-23
END MARKETING DATE: 0000-00-00


ACD Solution Modified HUMAN PRESCRIPTION DRUG Details:

Item DescriptionACD Solution Modified from AnazaoHealth Corporation
LABELER NAME: AnazaoHealth Corporation
DEA SCHEDULE:
ACTIVE STRENGTH: 8(mg/mL)
START MARKETING DATE: 2012-05-23
END MARKETING DATE: 0000-00-00
PRODUCT ID: 51808-201_651af678-d1d2-4e8e-8fe0-ae6c0ba11a16
PRODUCT NDC: 51808-201
APPLICATION NUMBER:

Other ANHYDROUS CITRIC ACID Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
AnazaoHealth CorporationACD Solution Modified